On 18 December 2024, the World Health Organization (WHO) prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency which can help to safely deliver WHO-recommended treatments to prevent relapse of Plasmodium vivax (P. vivax) infection.

News Medical

United States

Groundbreaking G6PD diagnostic test prequalified by WHO to ensure safe malaria treatment

Ad Fontes Media

Media Bias/Fact Check

Ian Birkby

It said each year, approximately 500,000 people die from malaria, with most of the fatalities occurring among children. The post WHO prequalifies diagnostic test for P. vivax malaria relapse appeared first on Premium Times Nigeria.

Premium Times Nigeria

Abuja

Municipal Area Coun

Federal Capital Territory

Nigeria

WHO prequalifies diagnostic test for P. vivax malaria relapse

World Health Organization (WHO) prequalifies diagnostic test to support safer administration of P. vivax malaria treatments

Zawya

News Ghana, Latest Updates and Breaking News of Ghana, AMA, https://newsghana.com.gh/who-prequalifies-diagnostic-test-to-support-safer-administration-of-p-vivax-malaria-treatments/
Decision reflects updated processes to improve efficiency, access © Thiago Poncio on behalf of MedAccess, MMV and PATHG6PD test device in use GENEVA, Switzerland, 10 January 2025 -/African Media Agency(AMA)/- On 18 December 2024, the World Health Organization (WHO) pr…

News Ghana

WHO prequalifies diagnostic test to support safer administration of P. vivax malaria treatments

Share…Milestone Aims to Improve Safe, Equitable Malaria Care Globally The World Health Organisation (WHO) has achieved a significant milestone in the global fight against malaria by prequalifying the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency. This breakthrough promises to revolutionise the treatment of Plasmodium vivax (P. vivax) malaria by facilitating safer delivery of anti-relapse... The post WHO Prequalifi…

Newtelegraph

WHO Prequalifies First G6PD Diagnostic Test To Enhance P. Vivax Malaria Treatment

The World Health Organisation (WHO) has prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency, a critical tool for safely administering WHO-recommended treatments to prevent relapse of Plasmodium vivax (P. vivax) malaria. By Franca Ofili The World Health Organisation (WHO) has prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency, a critical tool for safely adminis…

Newsdiaryonline

Decision reflects updated processes to improve efficiency, access © Thiago Poncio on behalf of MedAccess, MMV and PATHG6PD test device in use GENEVA, Switzerland, 10 January 2025 -/African Media Agency(AMA)/- On 18 December 2024, the World Health Organization (WHO) prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency which can help to safely deliver WHO-recommended treatments to prevent relapse of Plasmo…

African Media Agency

Nnu.ng - Nigeria News Update.

The World Health Organisation (WHO) has officially prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency, a key tool for safely administering treatments that prevent Plasmodium vivax (P. vivax) malaria relapse. In a statement on Wednesday, WHO emphasized that this prequalification marks a major step toward improving global access to essential health solutions. The […] The post WHO approves G6PD diagnostic…

Idoma Voice Newspaper

WHO approves G6PD diagnostic test, advancing malaria relapse prevention

P. vivax. Credit: Wikipedia.org On 18 December 2024, the World Health Organization (WHO) prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency which can help to safely deliver WHO-recommended treatments to prevent relapse of Plasmodium vivax (P. vivax) infection. The prequalification of this G6PD diagnostic test marks a significant milestone in facilitating safe and effective P. vivax malaria

Groundbreaking G6PD diagnostic test prequalified by WHO to ensure safe malaria treatment

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics